相关实验视频
Updated: May 24, 2025

13:19
Deep Neural Networks for Image-Based Dietary Assessment
Published on: March 13, 2021
8.9K
新的人工智能解释并验证了深度学习方法,以准确预测糖尿病
Ifra Shaheen1, Nadeem Javaid2, Nabil Alrajeh3
1ComSens Lab, International Graduate School of Artificial Intelligence, National Yunlin University of Science and Technology, Douliou, Yunlin, 64002, Taiwan.
Medical & biological engineering & computing
|March 4, 2025
概括
两种新的深度学习模型LeDNet和HiDenNet显著提高了早期糖尿病预测的准确性. 它们解决了阶级不平衡,提高了模型的解释性,优于可靠临床决策的现有方法.
科学领域:
- *计算生物学和机器学习在医疗保健中的应用.
- *开发先进的人工智能 (AI) 算法,用于疾病预测.
背景情况:
- * 糖尿病是一种关键的代谢状况,需要及早检测,以预防严重的慢性并发症和器官衰竭.
- * 现有的糖尿病预测模型的准确性很低,存在阶级不平衡问题,决策过程缺乏透明度.
- * 深度学习 (DL) 模型显示出潜力,但需要用于实际临床应用的增强.
研究的目的:
- * 引入两种新的深度学习模型LeDNet和HiDenNet,以提高早期和准确的糖尿病预测.
- * 解决当前糖尿病预测模型中阶级不平衡和解释性差的挑战.
- * 提高AI驱动的工具的可靠性和透明度,用于糖尿病诊断中的临床决策支持.
主要方法:
- * 开发和培训两种新型深度学习架构:LeDNet (LeNet + 双重注意网络) 和HiDenNet (高速公路网络 + 密集网络).
- *利用糖尿病健康指标数据集,通过多数加权少数人过量抽样来缓解阶级失衡.
- * K-fold交叉验证的应用用于模型稳定性评估和可解释AI (XAI) 技术 (LIME,SHAP) 的整合,以实现可解释性.
主要成果:
- *LeDNet的F1得分为85%,回忆率为84%,准确率为85%,精度为86%.
- * HiDenNet在准确度,F1分数,回忆和精度方面表现相似,均为85%或86%的精度.
- *这两种模型都超过了现有的最先进的深度学习模型,并通过XAI.提供了可解释的功能洞察力.
结论:
- *与目前的DL模型相比,LeDNet和HiDenNet在早期糖尿病预测的准确性和可靠性方面取得了显著的改进.
- * 提出的模型有效地处理了阶级不平衡,并提供了关键的解释性,解决了以前方法的关键局限性.
- *这些可解释的AI增强模型代表了临床决策和早期糖尿病诊断的有希望的工具,提高了透明度和信任.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
495
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Pathophysiology of Diabetes
842
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
842
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Management and Pharmacotherapy
227
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
227

